Thrombosis is the most frequent complication and the second cause of death in patients with malignant disease. Primary central nervous system non-Hodgkin's lymphoma represents a rare pathology. Resistance to APC is usually linked to a factor V (FV) gene mutation changing an Arg 506 to a Gln in the APC cleavage site.

De Lucia, D., De Francesco, F., Marotta, R., Maisto, G., Meo, D., Sessa, M., et al. (2005). Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma. EXPERIMENTAL ONCOLOGY, 27(2), 159-61.

Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma

Napolitano, Mariasanta;
2005-01-01

Abstract

Thrombosis is the most frequent complication and the second cause of death in patients with malignant disease. Primary central nervous system non-Hodgkin's lymphoma represents a rare pathology. Resistance to APC is usually linked to a factor V (FV) gene mutation changing an Arg 506 to a Gln in the APC cleavage site.
2005
De Lucia, D., De Francesco, F., Marotta, R., Maisto, G., Meo, D., Sessa, M., et al. (2005). Phenotypic APC resistance as a marker of hypercoagulability in primitive cerebral lymphoma. EXPERIMENTAL ONCOLOGY, 27(2), 159-61.
File in questo prodotto:
File Dimensione Formato  
Phenotypic APCr.pdf

Solo gestori archvio

Descrizione: Articolo pubblicato
Dimensione 137.38 kB
Formato Adobe PDF
137.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/350536
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact